.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Covington
Queensland Health
Cerilliant
McKinsey
Argus Health
Colorcon
Fish and Richardson
Baxter
UBS

Generated: July 26, 2017

DrugPatentWatch Database Preview

Amphetamine resin complex; dextroamphetamine resin complex - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for amphetamine resin complex; dextroamphetamine resin complex and what is the scope of amphetamine resin complex; dextroamphetamine resin complex patent protection?

Amphetamine resin complex; dextroamphetamine resin complex
is the generic ingredient in three branded drugs marketed by Ucb Inc and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifty-three drug master file entries for amphetamine resin complex; dextroamphetamine resin complex.

Summary for Generic Name: amphetamine resin complex; dextroamphetamine resin complex

Tradenames:3
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list53
Clinical Trials: see list1,645
Drug Prices:see low prices
DailyMed Link:amphetamine resin complex; dextroamphetamine resin complex at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc
BIPHETAMINE 20
amphetamine resin complex; dextroamphetamine resin complex
CAPSULE, EXTENDED RELEASE;ORAL010093-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ucb Inc
BIPHETAMINE 7.5
amphetamine resin complex; dextroamphetamine resin complex
CAPSULE, EXTENDED RELEASE;ORAL010093-009Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ucb Inc
BIPHETAMINE 12.5
amphetamine resin complex; dextroamphetamine resin complex
CAPSULE, EXTENDED RELEASE;ORAL010093-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Argus Health
UBS
McKinsey
Moodys
Johnson and Johnson
Baxter
McKesson
Farmers Insurance
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot